PL381614A1 - Pochodne indol-2-onu do leczenia chorób centralnego układu nerwowego, chorób układu pokarmowego oraz chorób układu krążenia - Google Patents
Pochodne indol-2-onu do leczenia chorób centralnego układu nerwowego, chorób układu pokarmowego oraz chorób układu krążeniaInfo
- Publication number
- PL381614A1 PL381614A1 PL381614A PL38161405A PL381614A1 PL 381614 A1 PL381614 A1 PL 381614A1 PL 381614 A PL381614 A PL 381614A PL 38161405 A PL38161405 A PL 38161405A PL 381614 A1 PL381614 A1 PL 381614A1
- Authority
- PL
- Poland
- Prior art keywords
- system diseases
- derivatives
- central nervous
- indoline
- treating central
- Prior art date
Links
- 208000024172 Cardiovascular disease Diseases 0.000 title 1
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 title 1
- 208000015606 cardiovascular system disease Diseases 0.000 title 1
- 208000015114 central nervous system disease Diseases 0.000 title 1
- 208000010643 digestive system disease Diseases 0.000 title 1
- -1 3,3-disubstituted indol-2-one Chemical class 0.000 abstract 1
- 210000000748 cardiovascular system Anatomy 0.000 abstract 1
- 210000003169 central nervous system Anatomy 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 210000005095 gastrointestinal system Anatomy 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU0400955A HU0400955D0 (en) | 2004-05-11 | 2004-05-11 | Pyridine derivatives of dialkyl oxindoles |
| HU0500463A HUP0500463A3 (en) | 2005-05-05 | 2005-05-05 | Pyridine derivatives of dialkyl-oxindoles |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL381614A1 true PL381614A1 (pl) | 2007-06-11 |
Family
ID=89985998
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL381614A PL381614A1 (pl) | 2004-05-11 | 2005-05-11 | Pochodne indol-2-onu do leczenia chorób centralnego układu nerwowego, chorób układu pokarmowego oraz chorób układu krążenia |
| PL05745439T PL1751138T3 (pl) | 2004-05-11 | 2005-05-11 | Pochodne indol-2-onu do leczenia chorób centralnego układu nerwowego, chorób układu pokarmowego oraz chorób układu krążenia |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL05745439T PL1751138T3 (pl) | 2004-05-11 | 2005-05-11 | Pochodne indol-2-onu do leczenia chorób centralnego układu nerwowego, chorób układu pokarmowego oraz chorób układu krążenia |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US20070232662A1 (pl) |
| EP (1) | EP1751138B9 (pl) |
| JP (1) | JP2007537228A (pl) |
| KR (1) | KR20070014189A (pl) |
| AT (1) | ATE382045T1 (pl) |
| AU (1) | AU2005240844A1 (pl) |
| BG (1) | BG109770A (pl) |
| CA (1) | CA2566426A1 (pl) |
| CZ (1) | CZ2006772A3 (pl) |
| DE (1) | DE602005004024T2 (pl) |
| EA (1) | EA010865B1 (pl) |
| ES (1) | ES2299033T3 (pl) |
| HR (2) | HRP20060403A2 (pl) |
| IL (1) | IL179030A0 (pl) |
| MX (1) | MXPA06013065A (pl) |
| NO (1) | NO20065661L (pl) |
| PL (2) | PL381614A1 (pl) |
| PT (1) | PT1751138E (pl) |
| RS (1) | RS20060622A (pl) |
| SK (1) | SK51062006A3 (pl) |
| WO (1) | WO2005108390A1 (pl) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20070011552A (ko) * | 2004-05-11 | 2007-01-24 | 에지스 지오기스제르기아르 엔와이알티. | ５-ｈｔ７ 수용체 활성제로서 알킬 옥스인돌의 피리딘유도체 |
| ES2329388T3 (es) | 2004-05-11 | 2009-11-25 | Egis Gyogyszergyar Nyrt | Derivados de 3-(((4-fenil)-piperazin-1-il)-alquil)-3-alquil-1,3-dihidro-2h-indol-2-ona y los compuestos correspondientes para el tratamiento de los trastornos del sistema nervioso central. |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8830312D0 (en) * | 1988-12-28 | 1989-02-22 | Lundbeck & Co As H | Heterocyclic compounds |
| CN1168716C (zh) * | 1998-04-22 | 2004-09-29 | 明治制果株式会社 | 光学活性四氢苯并吲哚衍生物 |
| FR2779429B1 (fr) * | 1998-06-03 | 2000-07-13 | Synthelabo | Derives d'oxindole, leurs preparations et leurs applications en therapeutique |
| AR035521A1 (es) * | 2000-12-22 | 2004-06-02 | Lundbeck & Co As H | Derivados de 3-indolina y composicion farmaceutica que los comprende |
-
2005
- 2005-05-11 DE DE602005004024T patent/DE602005004024T2/de not_active Expired - Fee Related
- 2005-05-11 US US11/596,471 patent/US20070232662A1/en not_active Abandoned
- 2005-05-11 EP EP05745439A patent/EP1751138B9/en active Active
- 2005-05-11 JP JP2007512358A patent/JP2007537228A/ja active Pending
- 2005-05-11 KR KR1020067025313A patent/KR20070014189A/ko not_active Application Discontinuation
- 2005-05-11 RS RSP-2006/0622A patent/RS20060622A/sr unknown
- 2005-05-11 CA CA002566426A patent/CA2566426A1/en not_active Abandoned
- 2005-05-11 PT PT05745439T patent/PT1751138E/pt unknown
- 2005-05-11 SK SK5106-2006A patent/SK51062006A3/sk not_active Application Discontinuation
- 2005-05-11 ES ES05745439T patent/ES2299033T3/es active Active
- 2005-05-11 WO PCT/HU2005/000051 patent/WO2005108390A1/en active IP Right Grant
- 2005-05-11 EA EA200602082A patent/EA010865B1/ru not_active IP Right Cessation
- 2005-05-11 AT AT05745439T patent/ATE382045T1/de not_active IP Right Cessation
- 2005-05-11 MX MXPA06013065A patent/MXPA06013065A/es active IP Right Grant
- 2005-05-11 AU AU2005240844A patent/AU2005240844A1/en not_active Abandoned
- 2005-05-11 CZ CZ20060772A patent/CZ2006772A3/cs unknown
- 2005-05-11 PL PL381614A patent/PL381614A1/pl not_active Application Discontinuation
- 2005-05-11 PL PL05745439T patent/PL1751138T3/pl unknown
-
2006
- 2006-11-02 IL IL179030A patent/IL179030A0/en unknown
- 2006-11-20 HR HR20060403A patent/HRP20060403A2/xx not_active Application Discontinuation
- 2006-12-06 NO NO20065661A patent/NO20065661L/no not_active Application Discontinuation
- 2006-12-11 BG BG109770A patent/BG109770A/bg unknown
-
2008
- 2008-03-20 HR HR20080129T patent/HRP20080129T3/xx unknown
-
2009
- 2009-07-09 US US12/500,335 patent/US20090281137A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20090281137A1 (en) | 2009-11-12 |
| DE602005004024T2 (de) | 2008-12-24 |
| JP2007537228A (ja) | 2007-12-20 |
| IL179030A0 (en) | 2007-03-08 |
| EA010865B1 (ru) | 2008-12-30 |
| AU2005240844A1 (en) | 2005-11-17 |
| DE602005004024D1 (de) | 2008-02-07 |
| HRP20060403A2 (en) | 2007-04-30 |
| BG109770A (bg) | 2008-05-30 |
| EP1751138B9 (en) | 2008-11-12 |
| CZ2006772A3 (cs) | 2007-03-14 |
| EP1751138B1 (en) | 2007-12-26 |
| RS20060622A (en) | 2008-06-05 |
| EP1751138A1 (en) | 2007-02-14 |
| HRP20080129T3 (en) | 2008-04-30 |
| CA2566426A1 (en) | 2005-11-17 |
| US20070232662A1 (en) | 2007-10-04 |
| KR20070014189A (ko) | 2007-01-31 |
| PT1751138E (pt) | 2008-02-25 |
| EA200602082A1 (ru) | 2007-04-27 |
| NO20065661L (no) | 2007-02-08 |
| MXPA06013065A (es) | 2007-05-04 |
| PL1751138T3 (pl) | 2008-05-30 |
| SK51062006A3 (sk) | 2007-04-05 |
| ATE382045T1 (de) | 2008-01-15 |
| WO2005108390A1 (en) | 2005-11-17 |
| ES2299033T3 (es) | 2008-05-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY144483A (en) | 1,2,3,4-tetrasubstituted indole for the treatment of respiratory diseases | |
| TNSN05045A1 (en) | Indole or benzimidazole derivatives for modulating ikappab kinase | |
| EA200600048A1 (ru) | Производные бензазепина, используемые для лечения заболеваний, ассоциированных с 5-ht-рецептором | |
| NO20064325L (no) | Heteroarylaminopyrazolderivativer nyttige for behandling av diabetes | |
| SE0303180D0 (sv) | Novel compounds | |
| SE0302232D0 (sv) | Novel Compounds | |
| MY133624A (en) | Thio-substituted indole acetic acid derivatives for the treatment of respiratory disease | |
| YU21702A (sh) | Supstituisani indoli za moduliranje nfkb aktivnosti | |
| TW200616953A (en) | Indole, indazole or indoline derivatives | |
| UA96785C2 (uk) | Заміщені похідні оксиндолу та їх застосування як лігандів рецептора вазопресину | |
| MX2007011695A (es) | Derivados de oxindol sustituido, medicamentos que contienen dichos derivados y uso de los mismos. | |
| MX2007011698A (es) | Derivados de oxindol sustituido, medicamentos que contienen dichos derivados y uso de los mismos. | |
| MY141528A (en) | Anilinopyrazole derivatives useful for the treatment of diabetes | |
| EA200600071A1 (ru) | Производные n-фенилпиперазина и способы профилактики или лечения заболеваний, связанных с 5ht-рецептором | |
| UA106200C2 (uk) | Заміщені похідні оксіндолу та їхнє застосування для лікування захворювань, залежних від вазопресину | |
| UA86873C2 (en) | SUBSTITUTED ARYL 1,4-PYRAZlNE DERIVATIVES | |
| NO20071466L (no) | 3-substituerte-5- og 6-aminoalkyl indol-2-karboksylsyreamider og relaterte analoger som inhibitorer av kaseinkinase IE | |
| EA200602083A1 (ru) | Новые пиперазиновые производные диалкилоксиндолов | |
| PL381614A1 (pl) | Pochodne indol-2-onu do leczenia chorób centralnego układu nerwowego, chorób układu pokarmowego oraz chorób układu krążenia | |
| EA200602081A1 (ru) | Пиридиновые производные алкилоксиндолов в качестве агентов, активных в отношении рецептора 5-нт7 | |
| EA200602084A1 (ru) | Пиперазиновые производные алкилоксиндолов | |
| EA200602080A1 (ru) | Пиперазиновые производные алкилоксиндолов | |
| UA86978C2 (en) | Piperazine derivatives of dialkyl oxindoles | |
| DE602005024430D1 (de) | Dibenzosuberon-derivate | |
| UA86809C2 (en) | Piperazine derivatives of alkyl oxindoles |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |